| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/27/2004 | US6727246 Enhancement of cognition and memory in human diseases such as alzheimer's |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6726923 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix |
| 04/27/2004 | CA2118929C (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
| 04/23/2004 | CA2445817A1 Novel derivatives of imidazoline, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2004 | WO2004033681A1 Substance having activity of promoting platelet aggregation |
| 04/22/2004 | WO2004033674A1 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
| 04/22/2004 | WO2004033620A2 Methods and compositions for therapeutic use of rna interference |
| 04/22/2004 | WO2004033502A1 Chitosan-containing polysaccharide, process for producing the same and use thereof |
| 04/22/2004 | WO2004033447A1 Imidazole derivatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 04/22/2004 | WO2004033444A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 04/22/2004 | WO2004033437A1 Dibenzoxazepine |
| 04/22/2004 | WO2004033429A1 Crystalline 2- `(2-aminoethoxy) methyl!-4-(2-chlorophenyl) -3-ethoxycarbonyl-5-methoxycarbonyl-6- methyl-1, 4-dihydropyridine maleate salt (amplodipine) |
| 04/22/2004 | WO2004033412A1 Novel beta mimetics with extended duration of action, method for production and use thereof as medicaments |
| 04/22/2004 | WO2004032965A1 Endogenous repair factor production promoters |
| 04/22/2004 | WO2004032942A1 Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin |
| 04/22/2004 | WO2004032941A1 Pharmaceutical compositions containing polydatin or its salts and their application |
| 04/22/2004 | WO2004032917A1 Composition for preventing/treating the expression of clinical symptom in disease caused by mitochondrial dysfunction |
| 04/22/2004 | WO2004032871A2 Piperazine and piperazinone inhibitors of factor xa |
| 04/22/2004 | WO2004032840A2 Compounds, compositions, and methods |
| 04/22/2004 | WO2004032836A2 Antidiabetic beta-amino heterocylcic dipeptidyl peptidase inhibitors |
| 04/22/2004 | WO2004032708A2 Vasoregulating compounds and methods of their use |
| 04/22/2004 | WO2004022544A8 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 04/22/2004 | WO2004020430A3 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/22/2004 | WO2004018431A3 Novel phenanthridines |
| 04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 04/22/2004 | WO2004009784A3 Novel inhibitors of kinases |
| 04/22/2004 | WO2004005310A3 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 04/22/2004 | WO2004005243A3 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives |
| 04/22/2004 | WO2004003201A3 Antisense modulation of lrh1 expression |
| 04/22/2004 | WO2004002986A3 Novel benzimidazole derivatives |
| 04/22/2004 | WO2003101958A3 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 04/22/2004 | WO2003087318A9 Truncated 24 kda basic fibroblast growth factor |
| 04/22/2004 | WO2003078403A3 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase |
| 04/22/2004 | WO2003070965A8 The eaat2 promoter and uses thereof |
| 04/22/2004 | WO2003068937A3 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 04/22/2004 | WO2003064625A3 Oligonucleotide compositions with enhanced efficiency |
| 04/22/2004 | WO2003029428A8 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/22/2004 | WO2003005999A8 Methods of treating cytokine mediated diseases |
| 04/22/2004 | WO2002100390A3 Improved method of treating the syndrome of coronary heart disease risk factors in humans |
| 04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002062970A8 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 04/22/2004 | WO1991007986A8 Method of treating septic shock |
| 04/22/2004 | US20040077896 Compounds for the treatment of metabolic disorders |
| 04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
| 04/22/2004 | US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer |
| 04/22/2004 | US20040077854 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 04/22/2004 | US20040077851 Receptor selective cannabimimetic aminoalkylindoles |
| 04/22/2004 | US20040077723 Administering mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA) to treat cardiovascular disorders |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077695 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 04/22/2004 | US20040077689 Abc expression promoters |
| 04/22/2004 | US20040077686 Inhibition of cyclooxygenase-2 activity |
| 04/22/2004 | US20040077685 Analogs of thalidomide as potential angiogenesis inhibitors |
| 04/22/2004 | US20040077684 Piperidinyl compounds that selectively bind integrins |
| 04/22/2004 | US20040077681 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 04/22/2004 | US20040077680 Ureaacylated indazole, benzisoxazole, or benzisothiazole derivative with monocyte chemoattractant protein inhibitors; antiinflammatory agents; autoimmune diseases; arthritis, asthma, atherosclerosis, diabetes |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077668 Compounds, compositins, and methods |
| 04/22/2004 | US20040077667 Quinazolinone derivatives |
| 04/22/2004 | US20040077664 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 04/22/2004 | US20040077658 Respiratory system, nervous system, brain, gastrointestinal and psychological disorders; chronic obstructive pulmonary disease; antiasthmatics, analgesics |
| 04/22/2004 | US20040077654 Anticholesterol agents; cardiovascular disorders |
| 04/22/2004 | US20040077640 Sodium channel modulators derived from 2-piperidylimidazoles |
| 04/22/2004 | US20040077639 Administering amidine derivative as antiasthmatic agents; chronic obstructive pulmonary disease treatment |
| 04/22/2004 | US20040077638 Carboxy-substituted dibenzo(b,e)azepine derivatives; anticoagulants; wound healing, antiarthritic, hypotensive agents |
| 04/22/2004 | US20040077634 Treatment of diseases characterized by excessive or insufficient cell death |
| 04/22/2004 | US20040077632 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/22/2004 | US20040077630 Allosteric adenosine receptor modulators |
| 04/22/2004 | US20040077620 Hypoglycemic agent |
| 04/22/2004 | US20040077612 Acting as prodrugs; higher concentration delivery of active material to target cell in hybrid form; decreasing side effects |
| 04/22/2004 | US20040077611 Triple therapy of angiotensin converting enzyme inhibitor epoxy-steroidal aldosterone antagonist and diuretic or digoxin for treatment of cardiovascular disease |
| 04/22/2004 | US20040077555 Substituted benzene derivatives or salts thereof |
| 04/22/2004 | US20040077540 Permeabilizing peptide; reversibly enhancing paracellular transport; inhibits homotypic binding |
| 04/22/2004 | US20040077536 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 04/22/2004 | US20040077535 Novel physiologically active peptide and use thereof |
| 04/22/2004 | US20040077529 Agonists; fused bicyclic systems substituted with aromatic group and aminoalkyl group |
| 04/22/2004 | US20040077525 Novel treatment |
| 04/22/2004 | US20040077079 Methods, kits and production plant for use in the production of cell colony forming units from a mammalian tissue explant and to the use of cells from such cell colony forming units in treatment of mammals suffering from tissue disorders |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040077002 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty; atherosclerosis |
| 04/22/2004 | US20040076986 A gene and/or a protein involved in the prevention or treatment of allergic diseases and dermatitis |
| 04/22/2004 | US20040076985 Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products, useful in preventing, ameliorating, or correcting dysfunctions or diseases including HIV infection, |
| 04/22/2004 | US20040076956 Oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA repair which are directed against the sequence; ascertaining genetic and/ or epigenetic parameters of DNA repair genes |
| 04/22/2004 | US20040076692 Mixtures of xanthine oxidase inhibitors and free radical scavangers, used as antiischemic agents or for prophylaxis of cardiovascular disorders |
| 04/22/2004 | US20040076676 Heat-melting polylactic acid having a weight-average molecular weight of 3,000-40,000 at 140-220 degrees C, cooling, pulverizing solidified polylactic acid, adding active materials, compressing powder in mold |
| 04/22/2004 | US20040076673 Oral pharmaceutical composition containing a block copolymer |
| 04/22/2004 | US20040076672 For treating cancer and other angiogenic-dependent diseases, and more specifically, to compositions comprising anti-angiogenic factors and polymeric carriers, stents which have been coated with such compositions |
| 04/22/2004 | US20040076628 Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/22/2004 | US20040076601 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter |
| 04/22/2004 | US20040076580 For diagnosis/treatment of thrombosis, embolism, atherosclerosis, inflammation or cancer; imaging |
| 04/22/2004 | US20040074504 Method and composition for inhibiting cardiovascular cell proliferation |
| 04/22/2004 | CA2501938A1 Compounds, compositions, and methods |
| 04/22/2004 | CA2501534A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 04/22/2004 | CA2501055A1 Novel betamimetics with extended duration of action, method for production and use thereof as medicaments |